These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 29382051)
1. Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds. Stefanachi A; Leonetti F; Pisani L; Catto M; Carotti A Molecules; 2018 Jan; 23(2):. PubMed ID: 29382051 [TBL] [Abstract][Full Text] [Related]
2. Recent Advancements and SAR Studies of Synthetic Coumarins as MAO-B Inhibitors: An Updated Review. Kaur P; Rangra NK Mini Rev Med Chem; 2024; 24(20):1834-1846. PubMed ID: 38778598 [TBL] [Abstract][Full Text] [Related]
4. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease. Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722 [TBL] [Abstract][Full Text] [Related]
6. Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents. Pisani L; Farina R; Catto M; Iacobazzi RM; Nicolotti O; Cellamare S; Mangiatordi GF; Denora N; Soto-Otero R; Siragusa L; Altomare CD; Carotti A J Med Chem; 2016 Jul; 59(14):6791-806. PubMed ID: 27347731 [TBL] [Abstract][Full Text] [Related]
7. Chemical library design, QSAR modeling and molecular dynamics simulations of naturally occurring coumarins as dual inhibitors of MAO-B and AChE. Boulaamane Y; Kandpal P; Chandra A; Britel MR; Maurady A J Biomol Struct Dyn; 2024; 42(4):1629-1646. PubMed ID: 37199265 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of new urolithin amides as multitarget agents against Alzheimer's disease. Shukur KT; Ercetin T; Luise C; Sippl W; Sirkecioglu O; Ulgen M; Coskun GP; Yarim M; Gazi M; Gulcan HO Arch Pharm (Weinheim); 2021 May; 354(5):e2000467. PubMed ID: 33511649 [TBL] [Abstract][Full Text] [Related]
9. Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease. Tao D; Wang Y; Bao XQ; Yang BB; Gao F; Wang L; Zhang D; Li L Eur J Med Chem; 2019 Jul; 173():203-212. PubMed ID: 31005056 [TBL] [Abstract][Full Text] [Related]
10. Deciphering the detailed structure-activity relationship of coumarins as Monoamine oxidase enzyme inhibitors-An updated review. Koyiparambath VP; Prayaga Rajappan K; Rangarajan TM; Al-Sehemi AG; Pannipara M; Bhaskar V; Nair AS; Sudevan ST; Kumar S; Mathew B Chem Biol Drug Des; 2021 Oct; 98(4):655-673. PubMed ID: 34233082 [TBL] [Abstract][Full Text] [Related]
11. Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases. Farina R; Pisani L; Catto M; Nicolotti O; Gadaleta D; Denora N; Soto-Otero R; Mendez-Alvarez E; Passos CS; Muncipinto G; Altomare CD; Nurisso A; Carrupt PA; Carotti A J Med Chem; 2015 Jul; 58(14):5561-78. PubMed ID: 26107513 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases. Matos MJ; Janeiro P; González Franco RM; Vilar S; Tatonetti NP; Santana L; Uriarte E; Borges F; Fontenla JA; Viña D Future Med Chem; 2014 Mar; 6(4):371-83. PubMed ID: 24635520 [TBL] [Abstract][Full Text] [Related]
13. Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer's disease. Zhang C; Lv Y; Bai R; Xie Y Bioorg Chem; 2021 Sep; 114():105070. PubMed ID: 34126574 [TBL] [Abstract][Full Text] [Related]
14. Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview. Ratre P; Kulkarni S; Das S; Liang C; Mishra PK; Thareja S Med Oncol; 2022 Dec; 40(1):41. PubMed ID: 36471176 [TBL] [Abstract][Full Text] [Related]
15. Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases. Mathew B; Parambi DGT; Mathew GE; Uddin MS; Inasu ST; Kim H; Marathakam A; Unnikrishnan MK; Carradori S Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900177. PubMed ID: 31478569 [TBL] [Abstract][Full Text] [Related]
16. Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study. Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Edraki N; Sharifzadeh M; Khanavi M; Akbarzadeh T Bioorg Chem; 2019 Mar; 83():303-316. PubMed ID: 30396115 [TBL] [Abstract][Full Text] [Related]
17. A Recent Look into Natural Products that have Potential to Inhibit Cholinesterases and Monoamine Oxidase B: Update for 2010-2019. Gulcan HO; Orhan IE Comb Chem High Throughput Screen; 2020; 23(9):862-876. PubMed ID: 31985374 [TBL] [Abstract][Full Text] [Related]
18. Coumarin: A Privileged Scaffold for the Design and Development of Antineurodegenerative Agents. Jameel E; Umar T; Kumar J; Hoda N Chem Biol Drug Des; 2016 Jan; 87(1):21-38. PubMed ID: 26242562 [TBL] [Abstract][Full Text] [Related]
19. Focusing on new monoamine oxidase inhibitors: differently substituted coumarins as an interesting scaffold. Matos MJ; Viña D; Vazquez-Rodriguez S; Uriarte E; Santana L Curr Top Med Chem; 2012; 12(20):2210-39. PubMed ID: 23231397 [TBL] [Abstract][Full Text] [Related]
20. Coumarins as cholinesterase inhibitors: A review. de Souza LG; Rennã MN; Figueroa-Villar JD Chem Biol Interact; 2016 Jul; 254():11-23. PubMed ID: 27174134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]